MCP
Mirador Capital Partners’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $699K | Buy |
563,670
+47,936
| +9% | +$59.4K | 0.11% | 116 |
|
|
2025
Q1 | $609K | Buy |
515,734
+289,148
| +128% | +$341K | 0.11% | 119 |
|
|
2024
Q4 | $415K | Buy |
226,586
+3,374
| +2% | +$6.17K | 0.08% | 140 |
|
|
2024
Q3 | $379K | Buy |
223,212
+161,818
| +264% | +$275K | 0.07% | 148 |
|
|
2024
Q2 | $84.1K | Sell |
61,394
-256,979
| -81% | -$352K | 0.02% | 185 |
|
|
2024
Q1 | $1.19M | Buy |
318,373
+265,835
| +506% | +$997K | 0.23% | 72 |
|
|
2023
Q4 | $515K | Buy |
52,538
+26,951
| +105% | +$264K | 0.11% | 114 |
|
|
2023
Q3 | $214K | Buy |
25,587
+14,112
| +123% | +$118K | 0.05% | 174 |
|
|
2023
Q2 | $153K | Sell |
11,475
-1,500
| -12% | -$20K | 0.04% | 180 |
|
|
2023
Q1 | $150K | Sell |
12,975
-3,058
| -19% | -$35.4K | 0.04% | 184 |
|
|
2022
Q4 | $131K | Buy |
+16,033
| New | +$131K | 0.03% | 186 |
|